Pharmafile Logo
Pharmafocus logo
Advanced Search
Sanofi image

Sanofi looking to diversify, may buy into animal health

December 11, 2014
Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …

News
Takeda image

Takeda eyes new drug licences following positive blood cancer studies

December 11, 2014
Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …

News
Boehringer image

Boehringer trials Pradaxa anti-bleeding antidote

December 11, 2014
Sales and Marketing BMS, Bayer, Boehringer, Eliquis, Pradaxa, ash, dabigatran, idarucizumab

Boehringer Ingelheim says that its investigational drug can safely reverse the blood-thinning effect of its anti-clotting drug Pradaxa (dabigatran). The …

News
Mylan image

Mylan shells out $32.5m to cover tax inversion fines

December 11, 2014
Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury

Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …

News
Tamoxifen image

Tamoxifen found to reduce breast cancer rates by 30%

December 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arimidex, NICE, anastrozole, astrazenea, breast cancer, tamoxifen

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …

News
Prescriptions image

Half of England on prescription drugs

December 11, 2014
Sales and Marketing England, HSCIC, NHS, doctors, prescribing, prescriptions

Almost half of the people in England are taking regular prescription medicines according to a new report by the Health …

News
kim_lemon

Kim Lemon named head of Liberation Unlimited

December 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, kim lemon, liberation unlimited

Marketing communications agency Liberation Unlimited has appointed Kim Lemon to head its operations. Since the UK-based comms firm joined the …

Appointment
Onyx pharma image

Treatment shifts away from chemotherapy for multiple myeloma

December 10, 2014
Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …

News

Private firms account for a third of NHS contracts

December 10, 2014
Medical Communications, Sales and Marketing Budget, Cameron, Hunt, NHS, Osborne, autumn, election, privatisation

A large percentage of NHS contracts in England have been awarded to private sector providers since 2013, according to data …

News
NHS image

Labour to extend cancer drugs funding if elected

December 10, 2014
Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …

News
Joe Jimenez image

EFPIA gives president role to Novartis chief executive

December 10, 2014
Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …

News
michel-de-rosen

Pharnext adds industry veteran to board

December 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …

Appointment
AZ image

AstraZeneca constipation drug gets EU nod

December 9, 2014
Sales and Marketing AstraZeneca, KODIAC, NKTR-118, PAMORA, moventig, naloxegol

AstraZeneca’s opioid-induced constipation drug Moventig has been approved by the European Commission. The first once-daily PAMORA tablet to be given …

News
Janssen image

NICE U-turn over Janssen arthritis drug

December 9, 2014
Sales and Marketing Janssen, NHS, NICE, Stelara, arthritis, ustekinumab

NICE has reversed its decision on Janssen’s Stelara and is now recommending the active psoriatic arthritis drug. The pricing watchdog …

News
bayer_healthcare

Mixed results for new leukaemia drugs

December 9, 2014
Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …

News
Sandoz image

Novartis biosimilar rivals Amgen offering

December 9, 2014
Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

News
Ranbaxy image

Ranbaxy and Sun Pharma merger approved

December 9, 2014
Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, cci, tamsulosin, tolterodine

The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …

News

Pfizer buys into gene therapy

December 9, 2014
Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …

News
bio_wim_sep_2014

Celgene appoints new UK general manager

December 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Wim Souverijns

Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …

Appointment
Novartis image

AZ triumphs in Nexium pay-for-delay trial

December 8, 2014
Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole

AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026